Encube is an integrated pharmaceutical company dedicated only to topical formulations viz. creams, ointments, gels, lotions, and solutions, with 24 years of formidable experience in contract development and manufacturing. Shri Mehul Shah, Promoter and Managing Director, incorporated Encube, on Sep 7, 1995, and commenced commercial operations on Mar 4, 1998.

Mission - Delivering exceptional value through science and world-class manufacturing

Vision - To become the preferred choice of customers for topical pharmaceuticals

Values -
1. Passion: “We will be the best one day in our chosen sphere of competence.”
2. Agility: “Soaring and scoring with change.”
3. Courage: “Beyond convention with conviction.”
4. Ownership: “Say what you mean. Do what you say.”

Our manufacturing facility in Madkaim - Goa, is the largest single-site topical manufacturing facility in the world. The Goa manufacturing facility is approved by leading global regulatory agencies including the US FDA. We are upcoming with our second state-of-the art manufacturing facility by Q1FY24 in Smart Industrial Park Pithampur, Indore, Madhya Pradesh.

Encube has 3 business segments: (a) contract manufacturing for domestic and export markets; (b) generic products under own brand for US market; and (c) branded products for the India consumer market.



Mehul Shah, Founder and Managing Director

Shri Mehul Shah has over 35+ years of entrepreneurial experience in technical and business leadership, building Encube into a global leader in topical formulations. His passion and expertise in topical formulations has defined growth and strategy for the company.

He has nurtured the next line of leadership at Encube. He has devoted his life on topical formulations - research, development, manufacturing, and commercialization and finds excitement in making complex topical formulations accessible to more patients and consumers around the world.

He also serves on the board of 3 companies in US - Intact Therapeutics Inc., Tioga Research Inc., and Enzen Therapeutics Inc. He was awarded Emerging Entrepreneur of the Year at Indian Pharma Awards 2015.


Encube Ethicals is a progressive contract development & manufacturing organization dedicated to topical semisolid formulations from Mumbai, India. We help our customers serve global markets with technology based, innovative, cost effective & consumer friendly topical products of the highest quality.


Innovation is in our DNA. Encube’s R&D Centre in Marol, Andheri (East) in Mumbai, is spread over 25,000 sq.ft., focusing on development of topical dermatological and cosmeceuticals products. Our R&D capabilities have been ever-evolving with respect to strategic orientation, operations and human resources since 2008, making path towards high quality branded and generic medicines for global markets. Our R&D team comprises of highly qualified 180+ scientists with proven expertise in formulation and analytical development, characterization and de-formulation with cumulative experience of more than 500 years in various ANDA, NDA, and 505 (b)(2) projects.

We also have R&D subsidiaries in US - Tioga Research and Enzen Therapeutics. Our R&D CoE is coming up in Lodha Palava Lifesciences Hub in Q3FY24; will be one of its kind in India with an integrated focus on science, people, and process capabilities. Today, we have the ability to work on more than 12 ANDA products every year and have world leading capabilities in complex generics including microspheres, liposomal, solid lipid nanoparticle products and transdermal patches.


Encube’s Goa manufacturing facility has installed capacity of 32 Crores units in 2-shifts derived from 13 bulk manufacturing lines and 20 filling and packing lines. We have strong capabilities in niche topical formulations including high-potency APIs. We are upcoming with our second state-of-the art manufacturing facility by Q1FY24 in Smart Industrial Park Pithampur, Indore, Madhya Pradesh.

Encube’s quality systems are designed to enable efficient production and stress-free working environment. We will conduct continuous improvement programs with industry consultants to build a culture of quality. Our Quality Control (QC) laboratory is a world-class laboratory with dedicated spaces to ensure effective and efficient deployment of analysis methods with capability of doing more than 90% tests in-house.


We are recognised by our customers, and government and regulatory bodies worldwide on quality, compliance, innovation, and cost excellence over the past 24 years. When a customer or business partner outsource their manufacturing with us, we bring our technical agility along with a responsive team that adds real value to sustain and grow their sales and bring delight. Our track record is a testimonial to our consistency and diversity of the products we make for our customers in various kinds of engagements.


Quality is at the heart of everything we do. Our outstanding regulatory compliance history serves as a strong foundation for our organization.

We are inspected by leading regulatory agencies across the globe.



For product queries, complaints or reporting adverse events, please click here.
  • If you have any general questions regarding the 'return of the recalled products' please contact Qualanex at 1-888-280-2040 (8:00am -9:00pm Eastern Time).
  • If you have any 'medical questions' regarding the drug recall, please contact Torrent Pharma Inc. at 1-800-912-9561 (8:00am -5:00pm Eastern Time).

Adverse Event/Product Complaint Reporting

Phone (Toll Free) : 1-833-285-4151
Email : [email protected]
Registered Office

B-803, HDIL Kaledonia Building, Sahar Road, Opp. Vijay Nagar Society, Andheri (East), Mumbai 400069.



Plot No. C1, Madkaim Indl Estate, Madkaim, Ponda Goa - 403 404


R&D Center

Unit 24, Steelmade Industrial Estate, Andheri(E), Mumbai - 400 069